{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:54:52Z","timestamp":1787867692397,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073560"],"award-info":[{"award-number":["82073560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program of Guangzhou","award":["2023A03J055"],"award-info":[{"award-number":["2023A03J055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inherited metabolic disorders (IMDs) usually occurs at young age and hence it severely threatening the health and life of young people. While so far there lacks a comprehensive study which can reveals China\u2019s nationwide landscape of IMDs. This study aimed to evaluate IMDs incidence and regional distributions in China at a national and province level to guide clinicians and policy makers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The retrospective study conducted from January 2012 to March 2021, we analyzed and characterized 372255 cases\u2019 clinical test information and diagnostic data from KingMed Diagnostics Laboratory. The samples were from 32 provincial regions of China, the urine organic acids were detected by gas chromatography-mass spectrometry (GC\u2013MS), amino acids and acylcarnitines in dried blood spots were detected by liquid chromatography-tandem mass spectrometry (LC\u2013MS\/MS). We did a statistical analysis of the distribution of the 16 most common IMDs in amino acid disorders and organic acidemias, and then paid special attention to analyze the age and regional distributions of different IMDs. The statistical analyses and visualization analysis were performed with the programming language R (version 4.2.1).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 4911 positive cases diagnosed, which was 1.32% of the total sample during the ten-year study period. Most diseases tended to occur at ages younger than 18\u00a0year-old. The Ornithine Transcarbamylase Deficiency tended to progress on male infants who were less than 28\u00a0days old. While the peak of the positive case number of Citrin Deficiency\u00a0disease (CD) was at 1\u20136\u00a0months. Different IMDs\u2019 had different distribution patterns in China\u2019s provinces. Methylmalonic Acidemias and Hyperphenylalaninemia had an imbalanced distribution pattern in China and its positive rate was significantly higher in North China than South China. Conversely, the positive rate of CD was significantly higher in South China than North China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Results of this work, such as the differences in distribution pattern of different diseases in terms of age, region, etc. provide important insights and references for clinicians, researchers and healthcare policy makers. The policy makers could optimize the better health screening programs for covering children and infants in specific ages and regions based on our findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02834-y","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T09:02:09Z","timestamp":1691053329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["China nationwide landscape of 16 types inherited metabolic disorders: a retrospective analysis on 372,255 clinical cases"],"prefix":"10.1186","volume":"18","author":[{"given":"Beibei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peichun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-7044","authenticated-orcid":false,"given":"Xinwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"issue":"1","key":"2834_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/09691413211021621","volume":"29","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Chen C, Sun X, Zhou D, Huang X, Dong H. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis. J Med Screen. 2022;29(1):12\u201320.","journal-title":"J Med Screen"},{"key":"2834_CR2","doi-asserted-by":"crossref","unstructured":"Yoon HR. Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry [published correction appears in Ann Pediatr Endocrinol Metab 2015 Dec;20(4):238]. Ann Pediatr Endocrinol Metab. 2015;20(3):119\u2013124.","DOI":"10.6065\/apem.2015.20.3.119"},{"issue":"4","key":"2834_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1177\/0884533615586201","volume":"30","author":"SW Boyer","year":"2015","unstructured":"Boyer SW, Barclay LJ, Burrage LC. Inherited metabolic disorders: aspects of chronic nutrition management. Nutr Clin Pract. 2015;30(4):502\u201310.","journal-title":"Nutr Clin Pract"},{"issue":"13","key":"2834_CR4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/rcm.3053","volume":"21","author":"OY Al-Dirbashi","year":"2007","unstructured":"Al-Dirbashi OY, Santa T, Al-Qahtani K, Al-Amoudi M, Rashed MS. Analysis of organic acid markers relevant to inherited metabolic diseases by ultra-performance liquid chromatography\/tandem mass spectrometry as benzofurazan derivatives. Rapid Commun Mass Spectrom. 2007;21(13):1984\u201390.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"2","key":"2834_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/ijns6020026","volume":"6","author":"SJ Moat","year":"2020","unstructured":"Moat SJ, George RS, Carling RS. Use of dried blood spot specimens to monitor patients with inherited metabolic disorders. Int J Neonatal Screen. 2020;6(2):26.","journal-title":"Int J Neonatal Screen."},{"key":"2834_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/978-1-60761-459-3_41","volume":"603","author":"PM Jones","year":"2010","unstructured":"Jones PM, Bennett MJ. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. Methods Mol Biol. 2010;603:423\u201331.","journal-title":"Methods Mol Biol"},{"issue":"13\u201314","key":"2834_CR7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.cca.2011.03.028","volume":"412","author":"W Sun","year":"2011","unstructured":"Sun W, Wang Y, Yang Y, et al. The screening of inborn errors of metabolism in sick Chinese infants by tandem mass spectrometry and gas chromatography\/mass spectrometry. Clin Chim Acta. 2011;412(13\u201314):1270\u20134.","journal-title":"Clin Chim Acta"},{"issue":"1\u20132","key":"2834_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cca.2008.02.015","volume":"392","author":"P Wasant","year":"2008","unstructured":"Wasant P, Liammongkolkul S, Kuptanon C, Vatanavicharn N, Sathienkijakanchai A, Shinka T. Organic acid disorders detected by urine organic acid analysis: twelve cases in Thailand over three-year experience. Clin Chim Acta. 2008;392(1\u20132):63\u20138.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2834_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/(SICI)1098-2787(1996)15:1<43::AID-MAS3>3.0.CO;2-B","volume":"15","author":"I Matsumoto","year":"1996","unstructured":"Matsumoto I, Kuhara T. A new chemical diagnostic method for inborn errors of metabolism by mass spectrometry-rapid, practical, and simultaneous urinary metabolites analysis. Mass Spectrom Rev. 1996;15(1):43\u201357.","journal-title":"Mass Spectrom Rev"},{"key":"2834_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/bs.acc.2019.04.001","volume":"92","author":"WS Phipps","year":"2019","unstructured":"Phipps WS, Jones PM, Patel K. Amino and organic acid analysis: Essential tools in the diagnosis of inborn errors of metabolism. Adv Clin Chem. 2019;92:59\u2013103.","journal-title":"Adv Clin Chem"},{"issue":"6","key":"2834_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0188-4409(02)00402-2","volume":"33","author":"M Wajner","year":"2002","unstructured":"Wajner M, Raymond K, Barschak A, et al. Detection of organic acidemias in Brazil. Arch Med Res. 2002;33(6):581\u20135.","journal-title":"Arch Med Res"},{"issue":"11","key":"2834_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.47102\/annals-acadmedsg.V35N11p804","volume":"35","author":"IK Tan","year":"2006","unstructured":"Tan IK, Gajra B, Lim MS. Study of inherited metabolic disorders in Singapore - 13 years experience. Ann Acad Med Singap. 2006;35(11):804\u201313.","journal-title":"Ann Acad Med Singap"},{"issue":"2","key":"2834_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jcla.21745","volume":"29","author":"L Han","year":"2015","unstructured":"Han L, Han F, Ye J, et al. Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry. J Clin Lab Anal. 2015;29(2):162\u20138.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"2834_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clinbiochem.2016.10.015","volume":"50","author":"MH Hampe","year":"2017","unstructured":"Hampe MH, Panaskar SN, Yadav AA, Ingale PW. Gas chromatography\/mass spectrometry-based urine metabolome study in children for inborn errors of metabolism: an Indian experience. Clin Biochem. 2017;50(3):121\u20136.","journal-title":"Clin Biochem"},{"key":"2834_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1172-6-44","volume":"6","author":"M Lindner","year":"2011","unstructured":"Lindner M, Gramer G, Haege G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases\u2013report of 10 years from South-West Germany. Orphanet J Rare Dis. 2011;6:44.","journal-title":"Orphanet J Rare Dis."},{"key":"2834_CR16","doi-asserted-by":"publisher","first-page":"763222","DOI":"10.3389\/fgene.2021.763222","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, He J, He L, et al. Spectrum analysis of inherited metabolic disorders for expanded newborn screening in a central chinese population. Front Genet. 2022;12:763222.","journal-title":"Front Genet."},{"issue":"6","key":"2834_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/jmd2.12325","volume":"63","author":"E Tiivoja","year":"2022","unstructured":"Tiivoja E, Reinson K, Muru K, et al. The prevalence of inherited metabolic disorders in Estonian population over 30 years: A significant increase during study period. JIMD Rep. 2022;63(6):604\u201313.","journal-title":"JIMD Rep."},{"issue":"12","key":"2834_CR18","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139.","journal-title":"Int J Surg"},{"issue":"4","key":"2834_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1620\/tjem.188.317","volume":"188","author":"M Kimura","year":"1999","unstructured":"Kimura M, Yamamoto T, Yamaguchi S. Automated metabolic profiling and interpretation of GC\/MS data for organic acidemia screening: a personal computer-based system. Tohoku J Exp Med. 1999;188(4):317\u201334.","journal-title":"Tohoku J Exp Med"},{"issue":"7","key":"2834_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/gim.2018.45","volume":"20","author":"RC Gallagher","year":"2018","unstructured":"Gallagher RC, Pollard L, Scott AI, et al. Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20(7):683\u201391.","journal-title":"Genet Med"},{"issue":"13\u201314","key":"2834_CR21","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jchromb.2010.02.020","volume":"878","author":"K Nakagawa","year":"2010","unstructured":"Nakagawa K, Kawana S, Hasegawa Y, Yamaguchi S. Simplified method for the chemical diagnosis of organic aciduria using GC\/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(13\u201314):942\u20138.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"2834_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10545-007-0543-9","volume":"30","author":"LS Han","year":"2007","unstructured":"Han LS, Ye J, Qiu WJ, Gao XL, Wang Y, Gu XF. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. J Inherit Metab Dis. 2007;30(4):507\u201314.","journal-title":"J Inherit Metab Dis"},{"key":"2834_CR23","unstructured":"R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/. Accessed on 1st July 2022."},{"issue":"7","key":"2834_CR24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/clinchem\/hvaa101","volume":"66","author":"H Alsharhan","year":"2020","unstructured":"Alsharhan H, Alharbi H, Priestley J, Ganetzky R, He M. Urinary uracil: a useful marker for ornithine transcarbamylase deficiency in affected males. Clin Chem. 2020;66(7):988\u20139.","journal-title":"Clin Chem"},{"issue":"5","key":"2834_CR25","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jimd.12403","volume":"44","author":"S Toquet","year":"2021","unstructured":"Toquet S, Spodenkiewicz M, Douillard C, et al. Adult-onset diagnosis of urea cycle disorders: results of a French cohort of 71 patients. J Inherit Metab Dis. 2021;44(5):1199\u2013214.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2834_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10545-015-9901-1","volume":"39","author":"P Burgard","year":"2016","unstructured":"Burgard P, K\u00f6lker S, Haege G, Lindner M, Hoffmann GF. Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders\u2013review and meta-analysis of observational studies published over more than 35 years. J Inherit Metab Dis. 2016;39(2):219\u201329.","journal-title":"J Inherit Metab Dis"},{"key":"2834_CR27","unstructured":"Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association, Huang S, Song F. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020;37(3):226\u2013234."},{"key":"2834_CR28","volume-title":"Sources of power: Alkaptonuria","author":"AF Sharabi","year":"2022","unstructured":"Sharabi AF, Goudar RB. Sources of power: Alkaptonuria. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"3","key":"2834_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-4632.2010.04668.x","volume":"50","author":"A Khaled","year":"2011","unstructured":"Khaled A, Kerkeni N, Hawilo A, Fazaa B, Kamoun MR. Endogenous ochronosis: case report and a systematic review of the literature. Int J Dermatol. 2011;50(3):262\u20137.","journal-title":"Int J Dermatol"},{"issue":"5","key":"2834_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104197","volume":"64","author":"PT Kisa","year":"2021","unstructured":"Kisa PT, Gunduz M, Dorum S, et al. Alkaptonuria in Turkey: clinical and molecular characteristics of 66 patients. Eur J Med Genet. 2021;64(5): 104197.","journal-title":"Eur J Med Genet"},{"issue":"9","key":"2834_CR31","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/liv.15267","volume":"42","author":"T Lv","year":"2022","unstructured":"Lv T, Jia J. Rare liver diseases are not rare in China. Liver Int. 2022;42(9):2023\u20138.","journal-title":"Liver Int"},{"issue":"9","key":"2834_CR32","doi-asserted-by":"publisher","first-page":"e74544","DOI":"10.1371\/journal.pone.0074544","volume":"8","author":"YZ Song","year":"2013","unstructured":"Song YZ, Zhang ZH, Lin WX, et al. SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China. PLoS One. 2013;8(9):e74544.","journal-title":"PLoS One."},{"key":"2834_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"MR Baumgartner","year":"2014","unstructured":"Baumgartner MR, H\u00f6rster F, Dionisi-Vici C, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.","journal-title":"Orphanet J Rare Dis."},{"key":"2834_CR34","doi-asserted-by":"crossref","unstructured":"Xiang L, Tao J, Deng K, et al. Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study [published correction appears in BMJ Open. 2020 Jan 10;10(1):e031474corr1]. BMJ Open. 2019;9(8):e031474","DOI":"10.1136\/bmjopen-2019-031474"},{"issue":"1","key":"2834_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13023-019-1268-1","volume":"14","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Shi Y, Shi Y, et al. Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report. Orphanet J Rare Dis. 2019;14(1):292.","journal-title":"Orphanet J Rare Dis."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02834-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02834-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02834-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:22:01Z","timestamp":1700612521000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02834-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2834"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02834-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by ethical review committee of Guangzhou KingMed Center for Clinical Laboratory. The approval ID is 2021025\u201301. Identity information, privacy, and sensitive data of patients were removed before starting analysis. Therefore, this article did not include privacy data, identity information or any sensitive data of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}